pert_well	avg_mol_weight	compound_well_mmoles_per_liter	dilution_factor	mfc_plate_name	pert_dose	pert_dose_unit	pert_id	pert_idose	pert_iname	pert_itime	pert_mfc_desc	pert_mfc_id	pert_time	pert_time_unit	pert_type	pert_vehicle	pert_vendor_id	purity	purity_annotation	smiles
A01	-666	-666	500	C-7159-01-LM3-046	-666	-666	DMSO	-666	DMSO	120 h	-666	-666	120	h	ctl_vehicle	DMSO	-666	-666	-666	-666
A07	581.49	5.0	500	C-7159-01-LM3-046	10.0	uM	BRD-A12230535	10.00 uM	Nutlin-3	120 h	Nutlin-3	BRD-A12230535-001-06-7	120	h	trt_cp	DMSO	S1061	94.34	ACCEPT	COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1
A08	581.49	1.66666666	500	C-7159-01-LM3-046	3.33333332	uM	BRD-A12230535	3.33 uM	Nutlin-3	120 h	Nutlin-3	BRD-A12230535-001-06-7	120	h	trt_cp	DMSO	S1061	94.34	ACCEPT	COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1
A09	581.49	0.55555555	500	C-7159-01-LM3-046	1.1111111	uM	BRD-A12230535	1.11 uM	Nutlin-3	120 h	Nutlin-3	BRD-A12230535-001-06-7	120	h	trt_cp	DMSO	S1061	94.34	ACCEPT	COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1
C19	384.237	10.053690821	500	C-7159-01-LM3-046	20.107381642	uM	BRD-K88510285	20.11 uM	Bortezomib	120 h	Bortezomib	BRD-K88510285-001-23-6	120	h	trt_cp	DMSO	S1013	-666	-666	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O
C20	384.237	10.053690821	500	C-7159-01-LM3-046	20.107381642	uM	BRD-K88510285	20.11 uM	Bortezomib	120 h	Bortezomib	BRD-K88510285-001-23-6	120	h	trt_cp	DMSO	S1013	-666	-666	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O
C21	384.237	10.053690821	500	C-7159-01-LM3-046	20.107381642	uM	BRD-K88510285	20.11 uM	Bortezomib	120 h	Bortezomib	BRD-K88510285-001-23-6	120	h	trt_cp	DMSO	S1013	-666	-666	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O
C22	475.6208	9.99956267682	500	C-7159-01-LM3-046	19.99912535364	uM	BRD-K60230970	20.00 uM	MG-132	120 h	MG-132	BRD-K60230970-001-19-1	120	h	trt_cp	DMSO	S2619	-666	-666	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O
C23	475.6208	9.99956267682	500	C-7159-01-LM3-046	19.99912535364	uM	BRD-K60230970	20.00 uM	MG-132	120 h	MG-132	BRD-K60230970-001-19-1	120	h	trt_cp	DMSO	S2619	-666	-666	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O
C24	475.6208	9.99956267682	500	C-7159-01-LM3-046	19.99912535364	uM	BRD-K60230970	20.00 uM	MG-132	120 h	MG-132	BRD-K60230970-001-19-1	120	h	trt_cp	DMSO	S2619	-666	-666	CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O
D01	450.337	5.0	500	C-7159-01-LM3-046	10.0	uM	BRD-K78431006	10.00 uM	Crizotinib (PF-02341066)	120 h	Crizotinib (PF-02341066)	BRD-K78431006-001-11-0	120	h	trt_cp	DMSO	S1068	89.1	ACCEPT	C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl
D02	450.337	1.66666666667	500	C-7159-01-LM3-046	3.33333333334	uM	BRD-K78431006	3.33 uM	Crizotinib (PF-02341066)	120 h	Crizotinib (PF-02341066)	BRD-K78431006-001-11-0	120	h	trt_cp	DMSO	S1068	89.1	ACCEPT	C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl
D03	450.337	0.555555555556	500	C-7159-01-LM3-046	1.1111111111120002	uM	BRD-K78431006	1.11 uM	Crizotinib (PF-02341066)	120 h	Crizotinib (PF-02341066)	BRD-K78431006-001-11-0	120	h	trt_cp	DMSO	S1068	89.1	ACCEPT	C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl
